Gimv transfers stake in Equipe Zorgbedrijven - Dutch group of specialised care clinics - to Nordic Capital Gimv transfers stake in Equipe Zorgbedrijven - Dutch group of specialised care clinics - to Nordic Capital Gimv transfers stake in Equipe Zorgbedrijven - Dutch group of specialised care clinics - to Nordic Capital

Gimv transfers stake in Equipe Zorgbedrijven - Dutch group of specialised care clinics - to Nordic Capital


Equipe Zorgbedrijven today announces an important step in its further (international) growth. Following the group's successful development, based on its high-quality concept of specialist outpatient care, Gimv is transferring its stake in Equipe Zorgbedrijven to Nordic Capital. Together, the founders, management and the new shareholder will focus on international expansion, digitalisation and innovation.

In 2015 Gimv acquired an equity stake in Equipe Zorgbedrijven (Eindhoven - NL,, a leading provider of specialist care through outpatient clinics in the Netherlands. Founded in 1995, the company is today the market leader in the Netherlands in hand and wrist surgery & therapy, has a strong position in aesthetic care and a growing presence in orthopaedics, ophthalmology & general surgery. In recent years, Equipe Zorgbedrijven’s management has focused on growing the company in a sustainable way to deliver high quality care, innovative treatments and improving standards. These in turn have opened the way to greater specialisation and additional sub-specialties, ultimately resulting in demonstrably better and meaningful care.

From the start, Equipe Zorgbedrijven has continuously invested in staff, care paths, clinics, facilities and an optimal IT infrastructure aimed at offering the right care in the right place at the right price. Creating sufficient critical mass, strengthening management and being at the forefront of developments and innovations have been essential here. During the years of Gimv's shareholding, Equipe Zorgbedrijven has grown strongly in size and quality.

The company currently has 6 larger clinics and over 20 outpatient centres, with 700 employees, including 130 physicians, where more than 110,000 treatments were performed in 2020 in hand and wrist surgery & therapy, cosmetic surgery & dermatology, orthopaedics, ophthalmology and proctology.

The transaction announced today will strengthen the company's relentless focus on quality care. Nordic Capital's investment will help Equipe Zorgbedrijven to facilitate the roll-out of its successful concept abroad and to invest further in its organisation and digitalisation to become an even better partner for both patients and staff.

Jak Dekker, CEO and co-founder of Equipe Zorgbedrijven, explains: "With Gimv's support, Equipe has been able to develop strongly in recent years. Through a number of targeted acquisitions we have taken our model for value-driven, integrated care provision to a higher level and expanded into multiple specialties. We have also invested in our network of clinics, our IT infrastructure and applications and have expanded our research activities. The partnership with Gimv has brought us to the point where we will be taking our first steps abroad. We are grateful to Gimv for this and look forward to working with Nordic Capital in realising our national and international ambitions."

Elderd Land, Partner in Gimv's Health & Care platform, on this growth story: "Gimv is proud to have been able to support Equipe Zorgbedrijven in its growth strategy where focus on quality and meaningful care has always been paramount. The company has developed strongly in recent years, growing both in size and quality. The result is a well-established player with a strong position in the Netherlands and now also great opportunities abroad. We thank the management of Equipe Zorgbedrijven for the successful and excellent cooperation and wish them - together with Nordic Capital - all the best in their further growth trajectory."

The transaction is subject to customary conditions, including the approval of the healthcare and competition authorities. This transaction has a positive impact of about 1 euro per share on the net asset value of Gimv as of 31 March 2021. No further financial details will be disclosed.